Brickell Stock Probability of Future Stock Price Finishing Over 0.12

BBI
 Stock
  

USD 3.46  0.04  1.14%   

Brickell Biotech's future price is the expected price of Brickell Biotech instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Brickell Biotech performance during a given time horizon utilizing its historical volatility. Brickell Biotech Price to Book Value is most likely to drop slightly in the upcoming years. The preceding year's Price to Book Value was reported at 1.06. The current Price to Sales Ratio is estimated to increase to 49.10, while Price to Earnings Ratio are projected to decrease to (0.50) .
  
Continue to Brickell Biotech Backtesting, Brickell Biotech Valuation, Brickell Biotech Correlation, Brickell Biotech Hype Analysis, Brickell Biotech Volatility, Brickell Biotech History as well as Brickell Biotech Performance. Please specify Brickell Biotech time horizon, a valid symbol (red box) and a target price (blue box) you would like Brickell Biotech odds to be computed.

Brickell Biotech Target Price Odds to finish over 0.12

The tendency of Brickell Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay above $ 0.12  in 90 days
 3.46 90 days 0.12 
close to 99
Based on a normal probability distribution, the odds of Brickell Biotech to stay above $ 0.12  in 90 days from now is close to 99 (This Brickell Biotech probability density function shows the probability of Brickell Stock to fall within a particular range of prices over 90 days) . Probability of Brickell Biotech price to stay between $ 0.12  and its current price of $3.46 at the end of the 90-day period is about 16.86 .
Considering the 90-day investment horizon the stock has the beta coefficient of 1.19 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Brickell Biotech will likely underperform. Additionally The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Brickell Biotech is significantly underperforming DOW.
   Brickell Biotech Price Density   
       Price  

Predictive Modules for Brickell Biotech

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Brickell Biotech. Regardless of method or technology, however, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Brickell Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Brickell Biotech in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.254.9915.06
Details
Intrinsic
Valuation
LowReal ValueHigh
0.183.6713.74
Details
1 Analysts
Consensus
LowTarget PriceHigh
4.004.004.00
Details
Earnings
Estimates (1)
LowProjected EPSHigh
-0.53-0.53-0.53
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Brickell Biotech. Your research has to be compared to or analyzed against Brickell Biotech's peers to derive any actionable benefits. When done correctly, Brickell Biotech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Brickell Biotech.

Brickell Biotech Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Brickell Biotech is not an exception. The market had few large corrections towards the Brickell Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Brickell Biotech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Brickell Biotech within the framework of very fundamental risk indicators.
α
Alpha over DOW
-1.1
β
Beta against DOW1.19
σ
Overall volatility
1.88
Ir
Information ratio -0.11

Brickell Biotech Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Brickell Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Brickell Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Brickell Biotech generated a negative expected return over the last 90 days
Brickell Biotech has high historical volatility and very poor performance
Brickell Biotech was previously known as BRICKELL BIOTECH INC and was traded on NASDAQ Exchange under the symbol VICL.
The company reported the last year's revenue of 479 K. Reported Net Loss for the year was (39.88 M) with loss before taxes, overhead, and interest of (27.83 M).
Brickell Biotech has about 17.29 M in cash with (39.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.52, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Brickell Biotech has a frail financial position based on the latest SEC disclosures
Latest headline from www.marketscreener.com: BRICKELL BIOTECH, INC. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS - Marketscreener.com

Brickell Biotech Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Brickell Stock often depends not only on the future outlook of the current and potential Brickell Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Brickell Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out6.83%
Short Percent Of Float6.98%
Float Shares2.48M
Shares Short Prior Month108.4k
Average Daily Volume Last 10 Day468.83k
Average Daily Volume In Three Month270.88k
Date Short Interest15th of July 2022

Brickell Biotech Technical Analysis

Brickell Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. Brickell Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Brickell Biotech. In general, you should focus on analyzing Brickell Stock price patterns and their correlations with different microeconomic environments and drivers.

Brickell Biotech Predictive Forecast Models

Brickell Biotech time-series forecasting models is one of many Brickell Biotech's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Brickell Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Brickell Biotech

Checking the ongoing alerts about Brickell Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Brickell Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Brickell Biotech Alerts

Brickell Biotech Alerts and Suggestions

Brickell Biotech generated a negative expected return over the last 90 days
Brickell Biotech has high historical volatility and very poor performance
Brickell Biotech was previously known as BRICKELL BIOTECH INC and was traded on NASDAQ Exchange under the symbol VICL.
The company reported the last year's revenue of 479 K. Reported Net Loss for the year was (39.88 M) with loss before taxes, overhead, and interest of (27.83 M).
Brickell Biotech has about 17.29 M in cash with (39.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.52, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Brickell Biotech has a frail financial position based on the latest SEC disclosures
Latest headline from www.marketscreener.com: BRICKELL BIOTECH, INC. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS - Marketscreener.com
Continue to Brickell Biotech Backtesting, Brickell Biotech Valuation, Brickell Biotech Correlation, Brickell Biotech Hype Analysis, Brickell Biotech Volatility, Brickell Biotech History as well as Brickell Biotech Performance. Note that the Brickell Biotech information on this page should be used as a complementary analysis to other Brickell Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Brickell Stock analysis

When running Brickell Biotech price analysis, check to measure Brickell Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brickell Biotech is operating at the current time. Most of Brickell Biotech's value examination focuses on studying past and present price action to predict the probability of Brickell Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Brickell Biotech's price. Additionally, you may evaluate how the addition of Brickell Biotech to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Is Brickell Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brickell Biotech. If investors know Brickell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brickell Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
9.2 M
Quarterly Revenue Growth YOY
27.58
Return On Assets
-0.85
Return On Equity
-1.76
The market value of Brickell Biotech is measured differently than its book value, which is the value of Brickell that is recorded on the company's balance sheet. Investors also form their own opinion of Brickell Biotech's value that differs from its market value or its book value, called intrinsic value, which is Brickell Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brickell Biotech's market value can be influenced by many factors that don't directly affect Brickell Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brickell Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Brickell Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brickell Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.